In MS, human cases rely more on the IL-12/STAT4 pathway driving the Th1-like phenotype (T-bet+), while mouse models frequently exhibit a Th17-like phenotype predominantly driven by IL-23/RORγt 11, 14, 28. This evidence concerns the gene STAT4 and myeloid sarcoma.